Table 3.
Subgroups | Included studies | OR (95% CI) |
Heterogeneity | |
---|---|---|---|---|
I2 (%) | P value | |||
Gender | ||||
Female | 2 | 1.96 (1.37, 2.81) | 0.0 | 0.000 |
Male | 2 | 0.94 (0.56, 1.59) | 0.0 | 0.829 |
Serum reactivity | ||||
Seropositive RA | 4 | 1.65 (1.24, 2.19) | 4.6 | 0.001 |
Seronegative RA | 4 | 1.70 (1.23, 2.36) | 0.0 | 0.001 |
Study type | ||||
Case-control study | 5 | 1.24 (0.10, 1.52) | 21.6 | 0.051 |
Cohort study | 3 | 1.74 (1.50, 1.99) | 28.6 | 0.000 |
Cross-sectional study | 1 | 0.92 (0.40, 2.12) | – | 0.845 |